In murine xenograft tumor models injected with hepatocarcinoma, melanoma or colorectal carcinoma cells, LXA4 is able to suppress tumor growth by targeting IL-10-producing regulatory B cells (Bregs) via dephosphorylation of signal transducer and activator of transcription 3 and ERK. The gene discussed is IL10; the disease is neoplasm.